Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01441375 · ClinicalTrials.gov registry record
Sickle Cell Disease: A Retrospective Chart Review
A clinical trial, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- 261
- Enrollment target
NCT01441375 is a clinical trial that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 261 participants.
The verdict
NCT01441375 has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- 261 participants
- Enrollment target
Study Summary
This study is a retrospective chart review of sickle cell patients and will include patients whom have received blood transfusions and those whom have not. Of the transfused patients, it will also include those whom have received chelation therapy and those whom have not.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 261 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01441375
The ClinicalTrials.gov registry entry for NCT01441375 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 261 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01441375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01441375 about?
NCT01441375 is a clinical study titled "Sickle Cell Disease: A Retrospective Chart Review". This study is a retrospective chart review of sickle cell patients and will include patients whom have received blood transfusions and those whom have not. Of the transfused patients, it will also include those whom have received chelation therapy and those whom have not.
What is the current status of trial NCT01441375?
This trial is currently completed. The enrollment target is 261 participants. The study started on 2011-07. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT01441375?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.